Financial Regulation

Groom Law Group adds top talent from DOL, HHS, and IRS, deepening its 'insider's view' on complex benefits and health regulations for clients.

A new partnership between Newrez and HomeVision aims to create an end-to-end AI underwriter, promising faster, cheaper loans for homebuyers.

Alerus Financial is set to release its Q4 results, capping a year of strategic growth. Investors watch to see if its unique model can sustain momentum.

Online education giant Stride, Inc. is embroiled in a legal battle over claims of inflated enrollment, systemic failures, and a 54% stock crash.

With quantum threats looming, BTQ Technologies adds a Wall Street veteran to its board, signaling a strategic move to build credibility with financial institutions.

Future FinTech and quant firm S1Quant partner to build a compliant bridge for institutional investors into the volatile world of cryptocurrency assets.

A landmark $1.2M order for its advanced LineaDNA validates the firm's biotech arm, but can scientific success balance its new, volatile crypto strategy?

Formerly Cybin, Helus Pharma's Nasdaq launch marks a pivotal shift towards commercializing its breakthrough depression and anxiety drug pipeline.

Indocia launches its non-custodial wallet beta, prioritizing tangible product over token hype in a strategic bid to win user trust in Web3.

With a blockbuster 2025 in the books, Boston Scientific's leadership faces intense scrutiny at upcoming investor events to prove its growth is sustainable.

Online broker PU Prime partners with Argentina's AFA for a new campaign, but can a human-centric message overcome industry skepticism and user complaints?

Interim CFO Donna Granato's departure marks a pivotal moment for Ayr Wellness as it completes a massive debt restructuring and transitions to a new entity.

Harris Evans launches a new wealth firm in a growing trend. But his success may hinge on navigating partners with both massive resources and troubled pasts.

Professional Diversity Network invests millions in an AI crypto token, a risky move signaling a dramatic pivot into the volatile world of Web3 finance.

A new AI assistant is being piloted in the UAE, promising to cut doctor paperwork by 50% and give patients more face-to-face attention.

Diamyd Medical's pivotal Phase 3 trial gets a nine-month acceleration, raising hopes for a new precision therapy that preserves insulin production.

A major acquisition turned sour, a 25% stock crash, and now a class action lawsuit. Inside Perrigo's costly infant formula venture and what it means.

A landmark executive order to reschedule cannabis and create a Medicare CBD program could unleash a $30B market and redefine the economics of the industry.

A cancer research firm is betting its future on Zcash, recruiting the crypto's top minds. Is this the start of institutional adoption for privacy coins?

Alvotech and Teva's settlement with Regeneron for an Eylea biosimilar paves the way for a 2026 launch, promising increased competition and lower costs.